Financial Shenanigans
Figures converted from GBP at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
The Forensic Verdict
Supreme is a Watch with credible Elevated drift. Reported five-year cash conversion is clean (CFO/Net income of 1.17 over FY2021-FY2025) and the FY2025 audit report was unqualified with no emphasis-of-matter paragraph and no non-audit fees. But three signals deserve underwriting: (1) acquisition-adjusted free cash flow turned negative in FY2025 ($33.2m of M&A absorbed all operating cash), (2) inventory grew 49% and receivables grew 18% on revenue growth of just 4% in FY2025, with the working-capital pressure intensifying in H1 FY2026 (operating cash flow collapsed to $5.1m from $15.1m), and (3) trade receivables and inventory are pledged to HSBC under the new Asset-Based Lending facility and the company pays "invoice discounting fees" ($557k FY2025) — confirming factoring is part of the cash machine. The grade would downgrade to Elevated if H2 FY2026 working capital does not normalise; it would upgrade to Clean if FY2026 reduces inventory days back below 60 and receivables sales fall away.
Forensic Risk Score (0–100)
Red Flags
Yellow Flags
5-yr CFO / Net Income
5-yr FCF / Net Income
FY2025 Accrual Ratio
AR Growth − Rev Growth (FY25, ppt)
Inventory Growth − Rev Growth (FY25, ppt)
Headline risk: Adjusted EBITDA — the basis for 80% of executive bonuses — was reported as growing 6% to $52.4m in FY2025, but acquisition-adjusted free cash flow was negative $4.8m in the same year. Investors should weight cash conversion, not the adjusted metric, when assessing run-rate earnings.
13-Shenanigan Scorecard
Of the 13 categories, four register red (factoring of receivables, acquisition-driven CFO flattering, working-capital lifeline, and the headline metric/cash conversion gap), five register yellow, and four are clean. The red flags cluster on cash-flow quality and the M&A-driven story, not on income-statement fabrication.
Breeding Ground
The structural conditions at Supreme are mixed: a controlling founder-CEO with operational dominance against an independent-majority Board, a single-metric bonus plan that recently shortened from three years to one, and an audit relationship that is clean on independence but has only been audited under increasing scope as M&A scales.
The breeding ground does not amplify the cash-flow red flags into critical territory. Independent NEDs and the audit committee provide real challenge, fees and behaviour at the auditor look clean, and there are no related-party customers. What does amplify risk is the alignment between (a) a 56%-controlling founder-CEO who personally drives M&A, (b) a bonus plan now anchored on a one-year Adjusted EBITDA target, and (c) a metric that benefits from acquisition timing and bargain-purchase accounting. That combination warrants the "Watch" grade rather than "Clean".
Earnings Quality
Earnings quality is mostly clean on the income-statement side, weaker on the balance-sheet side. Gross margin expanded to 32% from 29% (mix shift towards manufacturing-margin Clearly Drinks and away from low-margin disposables), reserves are not visibly being released, and there is no big-bath impairment pattern. The pressure point is receivables and inventory growing materially faster than revenue.
In FY2024, receivables grew 70.5% as revenue grew 42.2% — a 28-point gap as the disposable-vape windfall and acquisitions both fed AR. In FY2025, the pattern reverses for inventory: with revenue growth slowing to 4.4%, inventory grew 48.7%, a 44-point gap, as Typhoo and Clearly Drinks stocks consolidated and the disposable vape ban (1 June 2025) drove pre-emptive non-disposable inventory. Management's explanation is plausible, but the H1 FY2026 filing shows inventory rising further to $57.3m (six months later) — the working-capital absorption is not just a year-end optical issue.
DSO ended FY2025 at 67 days, the highest since FY2020 and 18 days above FY2023. DIO at 84 days is the highest since FY2022 and 27 days above FY2024. Payables (DPO) extended to 78 days from 63, partially funding the build — a working-capital lever that is sustainable until suppliers push back. The cash conversion cycle widened 21 days in a single year (52 days in FY2024 to 73 days in FY2025).
Reported PBT of $40.0m in FY2025 includes a $5.3m non-cash bargain-purchase gain on the Typhoo administration deal. Stripping that out reduces PBT to roughly $34.7m, materially below the FY2024 figure of $38.1m. Adjusted PBT of $39.1m (down 2% YoY) tells the cleaner underlying story — and, on that lens, FY2025 was a flat-to-down year, not a "+3%" year.
Cash Flow Quality
Reported headline cash conversion looks strong (5-year CFO/Net Income of 1.17 and FCF/Net Income of 1.02). The forensic concern is what happens after deal spend.
FY2025 is the standout year: free cash flow after acquisitions swung to negative $4.8m as the $33.2m M&A bill (Clearly Drinks $19.7m + Typhoo $13.2m) absorbed the entire $28.4m of post-capex free cash flow. Three-year cumulative FCF after acquisitions (FY2023-FY2025) is $25.4m on cumulative net income of $73.5m — a 35% true-cash-conversion ratio that is materially worse than the 1.07x FCF/NI headline.
Working capital was an $8.9m drag on CFO in FY2025 — and a $14.8m drag in H1 FY2026 alone. Pre-working-capital cash flow ($41m FY25) is healthy and grew strongly, but the gap between "what the business earns" and "what the business converts to cash" is widening as inventory and receivables consume the increment.
Receivables are pledged collateral. The H1 FY2026 going-concern note states: "The Group is funded by an external Asset Based Lending Arrangement with HSBC of $51.8m which is secured by an assignment of, and fixed charge over the trade debtors and inventory of Supreme Imports Limited." Combined with the $557k of invoice discounting fees disclosed within FY2025 operating cash flow, this confirms that part of receivables-driven CFO is sourced from financing-style monetisation of debtors. Investors should treat headline CFO with the factoring lens, not without it.
The structural shift from a Revolving Credit Facility to an Asset-Based Lending facility in March 2025 is a quiet but meaningful change: ABL pricing tracks the borrowing base (debtors + inventory), so factoring/discounting volume becomes a built-in feature of the funding stack, not an exception. $557k of invoice discounting fees in FY2025, $105k in H1 FY2026, is small relative to operating cash flow but proves the mechanism is live.
Metric Hygiene
Adjusted EBITDA is the single most important metric for Supreme — it sets 80% of executive bonuses, anchors the consensus figure ("FY26 consensus $50m Adjusted EBITDA"), and is the only profitability metric in the half-year highlights table. Investors should treat its construction with care.
The Adjusted earnings premium over GAAP net income has narrowed from 17% in FY2023 to 8% in FY2025 — a positive signal that adjustments are not widening as scale grows. The gap is small in absolute terms ($2.4m in FY25), so non-GAAP risk is contained even though the framing is favourable.
What to Underwrite Next
Five concrete diligence items will move the forensic grade in either direction over the next two reporting periods.
The forensic call. Supreme's accounting risk is a valuation haircut and a position-sizing limiter, not a thesis breaker. The numbers are not visibly fabricated; the audit is clean; the income statement reflects a real, growing FMCG business with margin expansion. But the mechanism behind reported "another highly cash-generative year" in FY2025 is a stretched working-capital cycle, factoring of receivables, and acquisitions consuming all of the post-capex cash. Underwriters should (i) discount the Adjusted EBITDA number when valuing on a multiple — apply at minimum a $5m haircut for the bargain-purchase gain — and (ii) require a CFO-to-Adjusted-EBITDA ratio of at least 0.55 (vs FY25's 0.62) to maintain conviction. If H2 FY2026 fails to recapture the working-capital outflow, the grade moves to Elevated and the position thesis tightens.